Abingworth

Contacts: Skipped - triage

Description

Abingworth is a leading transatlantic life sciences investment firm. Abingworth helps transform cutting-edge science into novel medicines by providing capital and expertise to top caliber management teams building world-class companies. Since 1973, Abingworth has invested in over 180 life science companies, leading to 46 M&As and 70+ IPOs. Our therapeutic focused investments fall into three categories: seed and early-stage, development stage, and clinical co-development. Abingworth supports its portfolio companies with a team of experienced professionals at offices in London, Menlo Park (California), and Boston. Abingworth became part of Carlyle (NASDAQ: CG) on 1 August 2022.

Location

London, England, United Kingdom

Industry

Venture Capital and Private Equity Principals

Investor Type

Private Equity

Target Sectors

—

Verticals

No verticals classified

Specialities

Investing in life sciences

Financials

Revenue

—

EBITDA

—

Employees

Founded

1973

Classify Status

Triage: pure_vc — Life sciences VC backing early-stage companies

Prospects

0 people

No prospects linked to this account.

Outreach History

Outreach sequencing tables are not yet in Supabase.